ACCESS CONFIRMATION21+ · RESEARCH USE ONLY
Trenix Labs provides information about products intended exclusively for controlled laboratory and research purposes.
Age eligibility does not make any product appropriate for personal, human, veterinary, diagnostic, or therapeutic use.
SEL · RESEARCH PROFILE
Synthetic research peptide
A synthetic tuftsin-related peptide studied mostly in preclinical and limited international research involving neuropeptide and immune-signaling pathways.
KEY HIGHLIGHTS
Synthetic tuftsin-related sequence
GABAergic gene-expression research
Neurotransmission models
No single confirmed target
Not FDA-approved in the U.S.
EXPLORE SELANK
Selank is a synthetic heptapeptide related to tuftsin, an endogenous tetrapeptide associated with immune function. It has been studied largely in Russian and preclinical research settings. It is not an FDA-approved drug in the United States.
There is no single confirmed molecular mechanism. Rat studies have reported changes in expression of genes involved in GABAergic signaling and other neurotransmitter systems, leading researchers to investigate possible allosteric or downstream modulation rather than simple binding to one established receptor. Immune-signaling effects have also been proposed.
Selank is used in research models exploring neuropeptide regulation, stress-related behavior, neurotransmission, gene expression, and neuroimmune crosstalk. These models can generate mechanistic hypotheses, but behavioral findings in animals and short-term gene-expression changes do not establish a human clinical effect.
Its tuftsin relationship places Selank at the intersection of neuropeptide and immune research. The peptide may affect networks of genes and signaling systems rather than acting as a highly selective receptor ligand. That breadth makes controlled, endpoint-specific experiments especially important.
EVIDENCE BOUNDARY
U.S. human safety, pharmacokinetics, dose-response, and effectiveness are not established. FDA has described important information gaps for human exposure. Preclinical gene-expression findings are not treatment claims, and product route, purity, aggregation, and impurities can materially affect risk.
READ THE SOURCES
These links provide context for the pathways and limitations described above. Studies of an ingredient or related molecule do not validate a specific Trenix batch or blend.
LOCAL FOLLOW-UP
Submit a research-product request and our local team will follow up about availability and documentation.